-
Loading metrics
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
-
Baruch Brenner ,
* E-mail: brennerb@clalit.org.il
Affiliation Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⨯ - Michal Sarfaty,
- Ofer Purim,
- Yulia Kundel,
- Limor Amit,
- Amir Abramovich,
- Udi Sadeh Gonik,
- Efraim Idelevich,
- Noa Gordon,
- Gal Medalia,
- Aaron Sulkes
http://orcid.org/0000-0002-1596-9362
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
- Baruch Brenner,
- Michal Sarfaty,
- Ofer Purim,
- Yulia Kundel,
- Limor Amit,
- Amir Abramovich,
- Udi Sadeh Gonik,
- Efraim Idelevich,
- Noa Gordon,
- Gal Medalia
x
- Published: July 8, 2016
- https://doi.org/10.1371/journal.pone.0157548